Related Experiment Videos
NSAIDs bound to methacrylic carriers: microstructural characterization and in vitro release analysis
A Gallardo1, C Parejo, J San Román
1Instituto de Ciencia y Tecnología de Polímeros, CSIC, Juan de la Cierva 3, 29006, Madrid, Spain. ictgr23@ictp.csic.es
Summary
New polymeric drugs offer controlled release of ibuprofen and ketoprofen over weeks. Drug release rates depend on copolymer composition, spacer type, and pH, with faster release at pH 9.
Area of Science:
- Polymer Chemistry
- Materials Science
- Drug Delivery Systems
Background:
- Chemically controlled drug delivery systems, or 'polymeric drugs', are synthesized using copolymers.
- These systems incorporate active pharmaceutical ingredients like ibuprofen or ketoprofen directly into the polymer structure via labile ester bonds.
Purpose of the Study:
- To prepare and characterize novel polymeric drugs based on 2-hydroxyethyl methacrylate (HEMA) and methacrylic derivatives containing ibuprofen or ketoprofen.
- To investigate the in vitro release kinetics of these drugs from the polymeric matrices under varying conditions.
Main Methods:
- Free radical polymerization in solution at 50°C to synthesize copolymers.
- Incorporation of three distinct spacer types (aromatic amide, aliphatic ester, combined) into the monomer structure.
- In vitro drug release studies at pH 7.4 and 9 with varying copolymer compositions (1-30 wt% active monomer).
Main Results:
- Microstructural analysis indicated a random distribution of monomer units in the copolymers.
- HEMA-rich copolymers showed isolated active drug residues, facilitating controlled release.
- Controlled drug release over several weeks was observed, influenced by spacer type, drug identity (ketoprofen faster than ibuprofen), copolymer composition, and pH.
Conclusions:
- The developed polymeric drugs demonstrate tunable, long-term drug release capabilities.
- Release profiles are significantly modulated by the chemical structure of the copolymer and environmental pH.
- These findings highlight the potential of these polymeric drugs for advanced therapeutic applications.